| Cash Flow | 2026-06-30 | 2026-03-31 |
|---|---|---|
| Net income (loss) | -450,528 | -14,006 |
| Stock-based compensation | 377,008 | 9,593 |
| Amortization of customer warrants | 44,262 | 2,053 |
| Depreciation and amortization | 24,376 | 18,175 |
| Non-cash lease expense | 23,329 | 15,775 |
| Non-cash interest expense | 19,653 | 18,949 |
| Provision for product warranties | 3,840 | 4,590 |
| Extinguishment of forward contract liability | 0 | - |
| Other | -1,151 | -959 |
| Accounts receivable | 60,730 | 12,208 |
| Inventories | -52,800 | 21,684 |
| Prepaid expenses and other assets | 124,708 | 57,603 |
| Accounts payable | 10,635 | -10,070 |
| Deferred revenue | 89,671 | 36,769 |
| Customer deposits | -125,754 | 13,966 |
| Other liabilities | 57,474 | 8,995 |
| Net cash flows used in operating activities | -59,823 | 12,335 |
| Purchases of property and equipment | 416,903 | 131,970 |
| Purchases of investments | 966,714 | 308,801 |
| Maturities and sales of investments | 310,300 | 204,155 |
| Net cash flows used in investing activities | -1,073,317 | -236,616 |
| Proceeds from initial public offering, net of underwriting discounts and commissions | 6,232,511 | - |
| Proceeds from sale of shares of series h redeemable convertible preferred stock | 0 | 1,014,249 |
| Costs incurred in connection with the sale of shares of series h redeemable convertible preferred stock | 0 | 218 |
| Proceeds from working capital loan | 0 | 1,004,571 |
| Proceeds from exercise of stock options | 14,906 | 5,315 |
| Proceeds from issuance of shares of class n common stock | 17 | 15,019 |
| Fees paid for revolving credit facility | 3,801 | - |
| Repurchases of early exercised stock options | 0 | - |
| Tax withholding from tender offer and initial public offering | 416,037 | 623 |
| Payments of deferred offering costs | - | 207 |
| Payments of deferred offering costs and other financing activities | 12,667 | - |
| Net cash flows provided by financing activities | 5,815,136 | 2,038,106 |
| Effect of exchange rate on cash | -273 | 911 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 4,681,723 | 1,814,736 |
| Cash, cash equivalents, and restricted cash beginning of period | 2,745,114 | 930,378 |
| Cash, cash equivalents, and restricted cash end of period | 7,426,837 | 2,745,114 |
Cerebras Systems Inc. (CBRS)
Cerebras Systems Inc. (CBRS)